Second-Line Treatment Options for Seizures Not Controlled with Oxcarbazepine

Introduction to Second-Line Therapy

The American College of Emergency Physicians recommends valproate as the preferred second-line treatment option for patients with seizures not controlled with oxcarbazepine, with levetiracetam as an alternative choice 1, 2, 3

Valproate has demonstrated high efficacy rates (88%) in controlling seizures refractory to initial treatment, making it an excellent second-line option 2, 3
The recommended dosing for valproate is 30 mg/kg IV infused at 6 mg/kg per hour followed by maintenance infusion of 1-2 mg/kg per hour 2
Valproate has been shown to be more effective than phenytoin as a second-line agent, with seizure control achieved in 79% versus 25% of patients 3
Valproate has a favorable safety profile with minimal cardiovascular side effects compared to phenytoin (no hypotension reported with valproate versus 12% with phenytoin) 3

Levetiracetam has demonstrated similar efficacy to valproate (73% vs 68%) in controlling refractory seizures 2, 3
The recommended dosing for levetiracetam is 30 mg/kg IV delivered at 5 mg/kg per minute 3
Multiple observational studies support levetiracetam's efficacy in status epilepticus with seizure cessation rates of 67-73% 2
Levetiracetam has minimal drug interactions and a favorable safety profile, making it particularly useful in patients with hepatic dysfunction or those on multiple medications 4

Phenytoin has a lower efficacy rate (56%) in terminating status epilepticus when used after benzodiazepines 3
Phenytoin has a higher risk of adverse effects including hypotension (12% of patients) compared to valproate 3
Phenytoin may still be considered in specific clinical scenarios where valproate and levetiracetam are contraindicated 2

The treatment algorithm recommends adding valproate as the preferred second-line agent (30 mg/kg loading dose) 2, 3
Levetiracetam (30 mg/kg) is recommended as an alternative second-line agent if valproate is contraindicated 2, 4
If seizures persist, consider phenytoin/fosphenytoin (18-20 mg/kg) 3
For refractory status epilepticus, consider anesthetic agents such as midazolam, propofol, or barbiturates 3

For pediatric patients, adjust dosing based on weight: valproate (30 mg/kg) or levetiracetam (30-40 mg/kg) 5, 4